Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHC.L Regulatory News (PHC)

  • There is currently no data for PHC

Director/PDMR Shareholding

3 May 2013 07:00

RNS Number : 9289D
Plant Health Care PLC
03 May 2013
 



Plant Health Care plc

Thursday, 03 May 2013

 

PLANT HEALTH CARE plc (THE "COMPANY")

 

Director/ PDMR Shareholding

 

On 01 May 2013, the Company approved the allotment of 23,727 ordinary shares of 1p ("Ordinary Shares") to the following current and former non-executive directors, in accordance with the Company's existing contractual arrangements, which comprise part of the non-executive directors' remuneration packages and are payable in lieu of a part of their fees. The shares were allotted at 89p per share, calculated at the closing middle market price derived from the Daily Official List on 25 April 2013.

 

Non-executive director

Value of remuneration used to purchase shares

Number of Ordinary Shares allotted

David Buckeridge(1)

£10,500.00

11,798

Former director(2)

£10,616.67

11,929

TOTAL:

23,727

(1) Allotted in the name of David Buckeridge Investigations Ltd., a personal service company(2) Allotted in the name of You and Your Health Ltd., a personal service company

 

Application has been made for 23,727 Ordinary Shares (the 'New Shares') to be admitted to trading on AIM and admission is expected to occur on 09 May 2013. The New Shares will rank pari passu with the Company's existing Ordinary Shares.

 

 

 

2. DIRECTOR'S HOLDINGS

 

Following the above-mentioned allotment of Ordinary Shares, the beneficial interest of the director concerned in the enlarged Ordinary Share capital of the Company is as shown below:

 

Name

Ordinary Share holding

Percentage of enlarged Ordinary Share capital

Share Options

LTIPs

David Buckeridge

166,553

0.24%

N/A

N/A

 

Following admission of the New Shares, the total issued share capital of the Company will be 70,529,298 Ordinary Shares, all of which have voting rights. There are no shares in treasury.

 

The above figure (70,529,298) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Plant Health Care plc under the FSA's Disclosure and Transparency Rules.

-: Ends :-

 

Enquiries:

Andrew C. Wood FCIS

Company Secretary

020 8866 5702

 

Nomura Code Securities

Clare Terlouw / Chris Golden

Tel: +44 (0)20 7776 1200

www.nomuracode.com

Powerscourt

Paul Durman / Nick Dibden/ Sophie Moate

Tel: +44 20 7250 1446

paul.durman@powerscourt-group.com

nick.dibden@powerscourt-group.com

sophie.moate@powerscourt-group.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSSUFWEFDSEFI
Date   Source Headline
28th Jun 202312:29 pmRNSHolding(s) in Company
27th Jun 20234:08 pmRNSHolding(s) in Company
27th Jun 20231:08 pmRNSDirector Shareholding
23rd Jun 20237:00 amRNSResult of Fundraising
22nd Jun 20234:35 pmRNSFundraising to raise up to US$3.6 million
14th Jun 20237:00 amRNSWilbur Ellis Agreement
13th Jun 20231:43 pmRNSResult of AGM
30th May 20237:00 amRNSHolding(s) in Company
24th May 20231:12 pmRNSHolding(s) in Company
19th May 20235:55 pmRNSPublication of Annual Report and Notice of AGM
18th May 20237:00 amRNSResult of Consultation
9th May 20237:00 amRNSPHC68949 granted first stage of approval in Brazil
2nd May 20237:10 amRNSResults for the year ended 31 December 2022
12th Apr 20232:33 pmRNSNotice of Results
5th Apr 20235:29 pmRNSHolding(s) in Company
8th Mar 20232:45 pmRNSExercise of Options
2nd Mar 20237:00 amRNSBiofungicide PHC279 Approved by US EPA
1st Mar 20237:00 amRNSDirector/PDMR Shareholding
6th Feb 20237:00 amRNSTrading Statement
30th Jan 202312:08 pmRNSSignificant Shareholder
18th Jan 20237:00 amRNSBoard Appointments
12th Jan 20237:00 amRNSNovozymes Distribution Agreement
9th Jan 20237:00 amRNSInvestor Presentation
22nd Dec 20227:00 amRNSNew Products Submitted for Regulatory Approval
28th Oct 20227:00 amRNSRegistration of Harpin in France
28th Oct 20227:00 amRNSNew distribution agreement with EDAF
27th Oct 20227:00 amRNSTrading Update
14th Oct 20225:11 pmRNSDirector/PDMR Shareholding
14th Oct 202210:39 amRNSDirector / PDMR Shareholding
26th Sep 20227:00 amRNSInterim Results
22nd Aug 20227:00 amRNSTrials agreement signed with Agrii UK
12th Aug 20227:00 amRNSGrant of Options
10th Aug 20225:04 pmRNSDirector/PDMR Shareholding
21st Jul 20222:41 pmRNSHolding(s) in Company
18th Jul 20227:02 amRNSInvestor Presentation
18th Jul 20227:00 amRNSPost-Close Trading Update
22nd Jun 202212:37 pmRNSResult of AGM
21st Jun 20227:00 amRNSCompletion of Nominated Adviser due diligence
20th Jun 20227:00 amRNSLong-term Harpin Production and Supply Agreement
6th Jun 20228:00 amRNSHolding(s) in Company
6th Jun 20228:00 amRNSHolding(s) in Company
1st Jun 20222:31 pmRNSDirector/PDMR Shareholding
25th May 20225:23 pmRNSHolding(s) in Company
23rd May 20227:30 amRNSAnnual Report & Accounts and Notice of AGM
23rd May 20227:00 amRNSNew distribution agreement with Nutrien
16th May 20227:00 amRNSHolding(s) in Company
12th May 20227:15 amRNSCEO appointment and Board changes
12th May 20227:00 amRNSResults for the year ended 31 December 2021
28th Apr 20227:00 amRNSChange of Adviser
21st Apr 20222:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.